Key clinical point: Opioid use among migraineurs is associated with markers of poor health, including high BMI and psychiatric comorbidities.
Major finding: About 36% of migraineurs who take acute prescription medications for headache use opioids.
Study details: An analysis of data for 2,388 participants in the Chronic Migraine Epidemiology and Outcomes Study.
Disclosures: Allergan funded the CaMEO study and paid Dr. Lipton for consulting services.
Lipton R et al. AHS 2019. Abstract 629332.